Differential expression of mTOR components in endometriosis and ovarian cancer: Effects of rapalogues and dual kinase inhibitors on mTORC1 and mTORC2 stoichiometry
Affiliations: Division of Biosciences, College of Health and Life Sciences, Brunel University London, Uxbridge UB8 3PH, UK, Queen Charlotte and Chelsea Hospital, London W120HS, UK, First Department of OB‑GYN, ‘Papageorgiou’ Hospital, University of Thessaloniki Medical School, Thessaloniki 54124, Greece, Ludwig Boltzmann Cluster Oncology and Division of Oncology, Department of Medicine I, Medical University Vienna, A‑1090 Vienna, Austria, Faculty of Health and Medical Sciences, School of Biosciences and Medicine, University of Surrey, Guildford, Surrey GU2 7XH, UK
- Published online on: October 31, 2018 https://doi.org/10.3892/ijmm.2018.3967
- Pages: 47-56
Copyright: © Rogers‑Broadway et al. This is an open access article distributed under the terms of Creative Commons Attribution License.